Stay updated with breaking news from Nasdaq Edsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edesa Biotech, Inc. (NASDAQ:EDSA – Get Free Report) CEO Pardeep Nijhawan acquired 5,000 shares of the stock in a transaction dated Monday, March 25th. The stock was acquired at an average price of $4.00 per share, for a total transaction of $20,000.00. Following the purchase, the chief executive officer now directly owns 341,702 shares in […]
Edesa Biotech, Inc. (NASDAQ:EDSA – Get Free Report) CEO Pardeep Nijhawan purchased 5,000 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $4.00 per share, for a total transaction of $20,000.00. Following the completion of the transaction, the chief executive officer now directly […]
Edesa Biotech (NASDAQ:EDSA – Get Free Report) is scheduled to post its quarterly earnings results on Thursday, February 8th. Edesa Biotech Price Performance Shares of EDSA opened at $5.07 on Wednesday. The company has a market capitalization of $16.02 million, a PE ratio of -2.01 and a beta of 0.31. Edesa Biotech has a one […]
Edesa Biotech (NASDAQ:EDSA – Get Free Report) will post its quarterly earnings results on Thursday, February 8th. Edesa Biotech Stock Performance EDSA stock opened at $5.07 on Wednesday. Edesa Biotech has a one year low of $2.46 and a one year high of $10.71. The stock has a market capitalization of $16.02 million, a PE […]
Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 31.3% of Edesa […]